SINGAPORE (Oct 30): Tianjin Zhong Xin Pharmaceutical Group Corporation posts an 11% decline in earnings to RMB 82.0 million ($16.8 million) for the 3Q ended September, from RMB 91.6 million a year ago.
Revenue fell 14% to RMB 1.31 billion in 3Q17, from RMB 1.51 billion a year ago.
In a filing to SGX on Monday, the group did not elaborate on reasons for the decline.
For more insights on corporate trends...
Sign In or Create an account to access our premium content.
Subscription Entitlements:
Less than $9 per month
Unlimited access to latest and premium articles
3 Simultaneous logins across all devices
Bonus unlimited access to online articles and virtual newspaper on The Edge Malaysia (single login)